Clinicopathologic Features of Pleomorphic Invasive Lobular Carcinoma: Comparison with Classic Invasive Lobular Carcinoma
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to identify the clinical and pathological factors that differentiate pleomorphic invasive lobular carcinoma (PILC) from classic invasive lobular carcinoma (CILC). Methods: We retrospectively reviewed the medical records of 65 patients (4.0% of all invasive breast cancer patients) who underwent surgical excision for invasive lobular carcinoma (ILC) between January 2000 and November 2013. All 65 patients were diagnosed with ILC with negative immunohistochemical staining for E-cadherin in the tumor cells. All hematoxylin and eosin slides of the previously diagnosed ILC were reviewed and confirmed by two expert pathologists and we compared the clinicopathologic features between CILC and PILC. Results: CILC was found in 46 cases and PILC, in 19 cases. Of the mammographic findings, a mass or asymmetric density was the most common feature (42.3% of all ILC patients). The most common ultrasonographic feature was a mass (94.9% of all ILC patients). Tumor multiplicity was noted in 10 patients (15.4%) among all ILC patients; eight patients (17.4%) had CILC and two patients (10.5%) had PILC. PILC patients had more grade III tumors (66.7% vs. 8.7%, p=0.002) and a higher Ki-67 labeling index (55.6% vs. 18.6%, p=0.004) than those with CILC. There were no statistical differences in the type of combined in situ component, extensive intraductal component, tumor size, lymphovascular invasion, stage, hormone receptor status, human epidermal growth factor receptor 2 status, distribution of intrinsic subtype, or imaging findings. Moreover, there was no significant difference in survival between CILC and PILC. Conclusion: PILC showed more pathological aggressiveness than CILC in terms of tumor grade and Ki-67 index.
Abstract
Purpose: The purpose of this study was to identify the clinical and pathological factors that differentiate pleomorphic invasive lobular carcinoma (PILC) from classic invasive lobular carcinoma (CILC). Methods: We retrospectively reviewed the medical records of 65 patients (4.0% of all invasive breast cancer patients) who underwent surgical excision for invasive lobular carcinoma (ILC) between January 2000 and November 2013. All 65 patients were diagnosed with ILC with negative immunohistochemical staining for E-cadherin in the tumor cells. All hematoxylin and eosin slides of the previously diagnosed ILC were reviewed and confirmed by two expert pathologists and we compared the clinicopathologic features between CILC and PILC. Results: CILC was found in 46 cases and PILC, in 19 cases. Of the mammographic findings, a mass or asymmetric density was the most common feature (42.3% of all ILC patients). The most common ultrasonographic feature was a mass (94.9% of all ILC patients). Tumor multiplicity was noted in 10 patients (15.4%) among all ILC patients; eight patients (17.4%) had CILC and two patients (10.5%) had PILC. PILC patients had more grade III tumors (66.7% vs. 8.7%, p=0.002) and a higher Ki-67 labeling index (55.6% vs. 18.6%, p=0.004) than those with CILC. There were no statistical differences in the type of combined in situ component, extensive intraductal component, tumor size, lymphovascular invasion, stage, hormone receptor status, human epidermal growth factor receptor 2 status, distribution of intrinsic subtype, or imaging findings. Moreover, there was no significant difference in survival between CILC and PILC. Conclusion: PILC showed more pathological aggressiveness than CILC in terms of tumor grade and Ki-67 index.
참고문헌 (28)
- Hayes D, "Invasive lobular carcinoma of the breast", Ulster Med J, 50, pp.105~108 (1981)
- du Toit RS, "Invasive lobular carcinomas of the breast: the prognosis of histopathological subtypes", Br J Cancer, 60, pp.605~609 (1989)
- Cocquyt V, "Lobular carcinoma in situ and invasive lobular cancer of the breast", Curr Opin Obstet Gynecol, 17, pp.55~60 (2005)
- Rakha EA, "Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast", Breast Cancer Res Treat, 111, pp.121~127 (2008)
- Middleton LP, "Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis", Am J Surg Pathol, 24, pp.1650~1656 (2000)
- Rakha EA, "Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade?", Mod Pathol, 26, pp.496~501 (2013)
- Jung HN, "Are the imaging features of the pleomorphic variant of invasive lobular carcinoma different from classic ILC of the breast?", Breast, 22, pp.324~329 (2013)
- Buchanan CL, "Is pleomorphic lobular carcinoma really a distinct clinical entity?", J Surg Oncol, 98, pp.314~317 (2008)
- Ciobanu M, "Breast invasive lobular carcinoma: a retrospective clinicopathologic study of 25 cases", Rom J Morphol Embryol, 53, pp.533~548 (2012)
- Jacobs M, "Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature", Ann Diagn Pathol, 16, pp.185~189 (2012)
- Hammond ME, "American Society of Clinical Oncology", College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version), 2010, pp.134, e48~e72
- Wolff AC, "Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology", College of American Pathologists clinical practice guideline update, 2013, pp.31, 3997~4013
- Polley MY, "An international study to increase concordance in Ki-67 scoring", Mod Pathol, 28, pp.778~786 (2015)
- Tashima R, "Evaluation of an optimal cut-off point for the Ki-67 index as a prognostic factor in primary breast cancer: a retrospective study", PLoS One, 10, pp.e0119565~ (2015)
- Hanagiri T, "Clinicopathological characteristics of invasive lobular carcinoma of the breast", Asian J Surg, 32, pp.76~80 (2009)
- Gudlaugsson E, "Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer", Breast Cancer Res Treat, 121, pp.35~40 (2010)
- Talman ML, "Invasive lobular breast cancer: prognostic significance of histological malignancy grading", Acta Oncol, 46, pp.803~809 (2007)
- Chung MA, "Optimal surgical treatment of invasive lobular carcinoma of the breast", Ann Surg Oncol, 4, pp.545~550 (1997)
- Sikora MJ, "Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systems", Steroids, 78, pp.568~575 (2013)
- Rakha EA, "Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes", Eur J Cancer, 44, pp.73~83 (2008)
- Fodor J, "Comparison of mastectomy with breast-conserving surgery in invasive lobular carcinoma: 15-year results", Rep Pract Oncol Radiother, 16, pp.227~231 (2011)
- Iorfida M, "Invasive lobular breast cancer: subtypes and outcome", Breast Cancer Res Treat, 133, pp.713~723 (2012)
- Wanis ML, "Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma", Am Surg, 79, pp.1119~1122 (2013)
- Orvieto E, "Clinicopathologic characteristics of invasive lobular carcinoma of the breast: results of an analysis of 530 cases from a single institution", Cancer, 113, pp.1511~1520 (2008)
- Cornford EJ, "Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis", Br J Radiol, 68, pp.450~453 (1995)
- Watermann DO, "Ultrasound morphology of invasive lobular breast cancer is different compared with other types of breast cancer", Ultrasound Med Biol, 31, pp.167~174 (2005)
- Caramella T, "Value of MRI in the surgical planning of invasive lobular breast carcinoma: a prospective and a retrospective study of 57 cases: comparison with physical examination, conventional imaging, and histology", Clin Imaging, 31, pp.155~161 (2007)
- Mann RM, "The effectiveness of MR imaging in the assessment of invasive lobular carcinoma of the breast", Magn Reson Imaging Clin N Am, 18, pp.259~276 (2010)